ERGOMED

Established in 1997, Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner. Our integrated service model helps life sciences companies meet regulatory obligations, maximize drug development success, and enhance the patient experience. Our expertise in oncology and rare disease drug development is extensive. With over 500 oncology studies and more than 360 rare disease studies conducted, our teams deliver speed, reliability, and predictability to your trials. This specialized knowledge ensures we meet your trial’s unique demands and provide the support necessary to bring innovative treatments to market. Choose Ergomed for your clinical trials and experience unparalleled expertise, dedicated support, and a commitment to bringing your innovative treatments to market efficiently and effectively.